Immune System Regulation

ISR Immune System Regulation Holding AB (ISR) is an innovation driven Research Company within the area of immunotherapy, based at Campus Solna in Stockholm, Sweden. The Company has a focus on preclinical and clinical research with the objective to develop novel drugs for curative treatments of viral infections and cancer, with the objective to be in the forefront of immunotherapy to develop curative drugs for treatment of cancer, HIV, HBV and other infections.

Cure viral infections and cancer and improve the quality of life of patients and their families

To find cures for viral infections and cancer and their complications through the development of drugs targeting the immune system

Start typing and press Enter to search